Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,793 signal articles · 210 in last 24h · 123,727 total before filter · latest 33m ago
210last 24h
1249last 7d
207● bullish (7d)
149● bearish (7d)
205publishers
AllMacro217Earnings419M&A103Regulatory23Product12Analyst8
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
The Crown Keeps Switching Hands: Apple Inc. (AAPL) vs NVIDIA Corporation (NVDA)
Insider Monkey13d agoneutral
The Crown Keeps Switching Hands: Apple Inc. (AAPL) vs NVIDIA Corporation (NVDA)

Apple Inc. (NASDAQ:AAPL) and NVIDIA Corporation (NASDAQ:NVDA) have traded the title of world’s most valuable company more than once in the past two weeks. Apple first edged ahead on Friday, July 17, at $4.88 trillion versus Nvidia’s roughly $4.86 trillion after Nvidia shares fell 3.5%. Nvidia returned to the top spot, then lost it again […]

Okta (OKTA) Is Considered a Good Investment by Brokers: Is That True?
Zacks13d agoneutral
Okta (OKTA) Is Considered a Good Investment by Brokers: Is That True?

According to the average brokerage recommendation (ABR), one should invest in Okta (OKTA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Air taxi firm Joby acquires defense tech company for $500 million
Reuters13d agoneutral
Air taxi firm Joby acquires defense tech company for $500 million

Joby Aviation said on Tuesday it would buy defense technology ‌company Resonant Sciences for about $500 million, as ‌it looks to scale its business in a growing ​defense market. Electric vertical take-off and landing aircraft (eVTOL) companies are focusing more on the military market amid ramped-up defense spending driven by wars in ‌Ukraine and the ⁠Middle East. Here are some more details: • Shares of Santa Cruz, California-based Joby ⁠fell 6.5% in premarket trading.

A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?
24/7 Wall St.13d agoneutral
A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?

BioCryst just turned profitable, its HAE drug Orladeyo is minting cash, and a rival's blockbuster acquisition just put the whole rare-disease sector in play. So which pharma giant has the most to lose by letting someone else snap it up first?

Tradr Expands Lineup with Leveraged Funds on Everspin, SiTime and UMC
Stocktwits13d agoneutral
Tradr Expands Lineup with Leveraged Funds on Everspin, SiTime and UMC

Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today announced the launch of three new leveraged single-stock ETFs. The Cboe-listed funds seek to deliver two times long (200%) the daily performance of a specific underlying stock.

Honeywell Aerospace (HONA) Trade Settles at Valuation Discount Following Spin-off
Insider Monkey13d agoneutral
Honeywell Aerospace (HONA) Trade Settles at Valuation Discount Following Spin-off

Merion Road Capital Management, an investment advisor, released its Q2 2026 Investor Letter. A copy of the letter can be downloaded here. Merion Road’s long-only large-cap portfolio increased 3.9% in the quarter, with YTD performance remaining flat. Despite underperforming the S&P, the strategy focuses on established industrial companies with strong growth potential and attractive cash […]

McDonald's (MCD) Faces Fresh US Growth Questions As Valuation Debate Heats Up
Simply Wall St.13d agoneutral
McDonald's (MCD) Faces Fresh US Growth Questions As Valuation Debate Heats Up

McDonald's (MCD) just reported second quarter results that kept revenue and earnings growing, while also revealing slower US comparable sales and rising competitive pressure from Burger King. At the same time, management is reshaping leadership and execution. See our latest analysis for McDonald's. Against that backdrop, McDonald's share price has softened, with the year to date share price return down 9.7% even though the stock has seen a 27.4% total shareholder return over five years. This...

Celsius (CELH) Stock Still Trades At A Premium After Setbacks
Simply Wall St.13d agoneutral
Celsius (CELH) Stock Still Trades At A Premium After Setbacks

Celsius Holdings stock is under pressure after a long slide in returns, while the valuation checks suggest the shares still do not screen as a clear bargain. With management changes following weak recent performance and a low value score, investors are weighing whether the current price fairly reflects the risks around execution and growth. Celsius Holdings has fallen 55.4% over the past 3 years, which raises the question of whether the pullback has fully reset expectations or if investors...